pentobarbital will reduce the level or influence of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Steer clear of coadministration of bedaquiline with solid CYP3A4 inducers as a consequence of prospective for lowered therapeutic resultpentobarbital will reduce the extent or impact of cilo